vs
Side-by-side financial comparison of OLIN Corp (OLN) and Solstice Advanced Materials Inc. (SOLS). Click either name above to swap in a different company.
OLIN Corp is the larger business by last-quarter revenue ($1.7B vs $969.0M, roughly 1.7× Solstice Advanced Materials Inc.). Solstice Advanced Materials Inc. runs the higher net margin — -3.6% vs -8.6%, a 5.0% gap on every dollar of revenue. On growth, Solstice Advanced Materials Inc. posted the faster year-over-year revenue change (6.8% vs -0.4%).
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.
Solstice Advanced Materials Inc. is a specialty advanced materials provider that develops, produces and distributes high-performance functional materials for renewable energy systems, consumer electronics, industrial manufacturing and advanced automotive sectors. The company focuses on material solutions that boost product durability, energy efficiency and operational performance for its global clients.
OLN vs SOLS — Head-to-Head
Income Statement — Q4 2025 vs Q3 2025
| Metric | ||
|---|---|---|
| Revenue | $1.7B | $969.0M |
| Net Profit | $-143.2M | $-35.0M |
| Gross Margin | 1.9% | 32.0% |
| Operating Margin | -9.4% | 17.9% |
| Net Margin | -8.6% | -3.6% |
| Revenue YoY | -0.4% | 6.8% |
| Net Profit YoY | -1517.8% | -123.0% |
| EPS (diluted) | $-1.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $969.0M | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | $907.0M | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $-143.2M | — | ||
| Q3 25 | $43.7M | $-35.0M | ||
| Q2 25 | $-2.8M | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $-25.2M | $152.0M | ||
| Q2 24 | $72.3M | — | ||
| Q1 24 | $47.8M | — |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 10.7% | 32.0% | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 8.5% | 36.6% | ||
| Q2 24 | 14.5% | — | ||
| Q1 24 | 12.7% | — |
| Q4 25 | -9.4% | — | ||
| Q3 25 | 4.8% | 17.9% | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 1.0% | 21.7% | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 5.9% | — |
| Q4 25 | -8.6% | — | ||
| Q3 25 | 2.6% | -3.6% | ||
| Q2 25 | -0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | -1.6% | 16.8% | ||
| Q2 24 | 4.4% | — | ||
| Q1 24 | 2.9% | — |
| Q4 25 | $-1.25 | — | ||
| Q3 25 | $0.37 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $-0.21 | — | ||
| Q2 24 | $0.62 | — | ||
| Q1 24 | $0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $417.0M |
| Total DebtLower is stronger | $2.8B | — |
| Stockholders' EquityBook value | $1.8B | $3.2B |
| Total Assets | $7.3B | $5.2B |
| Debt / EquityLower = less leverage | 1.55× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | — | ||
| Q3 25 | — | $417.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $175.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.8B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $2.0B | $3.2B | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.1B | $3.2B | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.2B | — |
| Q4 25 | $7.3B | — | ||
| Q3 25 | $7.6B | $5.2B | ||
| Q2 25 | $7.7B | — | ||
| Q1 25 | $7.7B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.5B | — | ||
| Q2 24 | $7.7B | — | ||
| Q1 24 | $7.6B | — |
| Q4 25 | 1.55× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.34× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 1.31× | — | ||
| Q1 24 | 1.24× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $321.2M | $289.0M |
| Free Cash FlowOCF − Capex | — | $41.0M |
| FCF MarginFCF / Revenue | — | 4.2% |
| Capex IntensityCapex / Revenue | — | 25.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $321.2M | — | ||
| Q3 25 | $26.7M | $289.0M | ||
| Q2 25 | $212.3M | — | ||
| Q1 25 | $-86.0M | — | ||
| Q4 24 | $141.7M | — | ||
| Q3 24 | $189.9M | — | ||
| Q2 24 | $90.6M | — | ||
| Q1 24 | $81.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-44.4M | $41.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-147.4M | — | ||
| Q4 24 | $90.7M | — | ||
| Q3 24 | $146.6M | — | ||
| Q2 24 | $34.1M | — | ||
| Q1 24 | $36.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | -2.6% | 4.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | -9.0% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 2.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | 25.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 2.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.61× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -71.67× | — | ||
| Q4 24 | 14.03× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.69× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |
SOLS
| Refrigerants | $400.0M | 41% |
| Research And Performance Chemicals | $126.0M | 13% |
| Electronic Materials | $103.0M | 11% |
| Other | $89.0M | 9% |
| Services | $64.0M | 7% |
| Alternative Energy Services | $63.0M | 7% |
| Safety And Defense Solutions | $53.0M | 5% |
| Healthcare Packaging | $49.0M | 5% |
| Affiliated Entity | $22.0M | 2% |